Corrigendum to The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 10, October 2023, 101095.
Nuss EE, Hoffman MK, Goudar SS, Kavi A, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bauserman M, Tembo AM, Chomba E, Carlo WA, Figueroa L, Krebs NF, Jessani S, Saleem S, Goldenberg RL, Kurhe K, Das P, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Bucher S, Goco N, Hemingway-Foday J, Moore J, McClure EM, Silver RM, Derman RJ, Patel A; Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group.
Nuss EE, et al. Among authors: krebs nf.
Am J Obstet Gynecol MFM. 2024 Apr;6(4):101309. doi: 10.1016/j.ajogmf.2024.101309. Epub 2024 Feb 23.
Am J Obstet Gynecol MFM. 2024.
PMID: 38395633
No abstract available.